Consolidated Balance Sheet (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2018	Dec. 31, 2017
Statement of Financial Position [Abstract]
Investments at value, cost	$ 2,970,306	$ 2,071,754
Financial derivatives–assets, at fair value Net cost	22,526	31,474
Repurchase agreements, cost	61,274	155,109
Investments sold short at value, proceeds	(844,604)	(640,202)
Financial derivatives-liabilities, at fair value Net proceeds	(19,019)	(27,463)
Other secured borrowings proceeds	(114,100)	(57,909)
Other secured financing, at fair value-Proceeds	$ (298,706)	$ (125,105)
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	29,796,601	31,335,938
Common stock, shares outstanding	29,796,601	31,335,938